Jun 14, 2024

Hey there! I have some exciting news to share with you today. First, researchers in the UK have discovered a potential explanation for why never-smokers with lung cancer may have worse outcomes than those who have smoked. It seems that a combination of genetic mutations in the epidermal growth factor gene and the p53 gene can lead to drug-resistant cells, which may explain the poor outcomes in never-smokers with lung cancer.

In other news, there’s a new study that sheds light on the mortality rate of anorexia. It turns out that individuals with anorexia who also have coexisting psychiatric disorders have nearly double the mortality rate. This underscores the importance of early intervention and specialized treatment for individuals with anorexia.

On the legislative front, Congress is making another attempt at requiring Medicare insurers to speed up reviews of requests to cover treatments. This bipartisan bill aims to help patients and doctors by streamlining the prior authorization process and has gained support from nearly 400 health organizations.

Additionally, federal health agencies have issued a warning about a shroom company’s edibles, as they may be linked to severe acute illnesses. This serves as a reminder of the importance of public health policy and the need for vigilance in regulating such products.

Lastly, there’s some good news in the field of nanoscience, as three scientists have won the 2024 Kavli nanoscience prize for their groundbreaking work in biomedicine. It’s incredible to see the impact that their research has had on the field.

I hope you found these updates as interesting as I did. Stay tuned for more exciting news in the world of healthcare and science. Have a great day!

Summy

Stay Well!